Brief: Ac Immune And Takeda Sign Exclusive Option And License Agreement For Active Immunotherapy

AC Immune AG

13/05/2024 12:27

May 13 (Reuters) - AC Immune SA  ACIU.O :
    * AC IMMUNE AND TAKEDA SIGN EXCLUSIVE OPTION AND LICENSE
AGREEMENT
FOR ACTIVE IMMUNOTHERAPY TARGETING AMYLOID BETA FOR ALZHEIMER’S
DISEASE
    * AC IMMUNE RECEIVES $100M UPFRONT FROM TAKEDA
    * AC IMMUNE ELIGIBLE FOR $2.1B IN POTENTIAL MILESTONES
    * AC IMMUNE SA - TAKEDA TO FUND FURTHER CLINICAL DEVELOPMENT
POST-OPTION EXERCISE

Source text for Eikon:  ID:nGNX6llvlt 
Further company coverage:  ACIU.O 

 ((Reuters.Briefs@thomsonreuters.com;))